Medical News

RSS

Brain size can predispose person to develop eating disorders

New research indicates that teens with anorexia nervosa have bigger brains than teens that do not have the eating disorder. That is according to a study by researchers at the University of Colorado's School of Medicine that examined a group of adolescents with anorexia nervosa and a group without.

23 Aug 2013

Scientists identify molecular mechanism that contributes to pancreatic cancer

New research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine could aid efforts to diagnose and treat one of the most lethal and hard-to-treat types of cancer.

23 Aug 2013

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

Two simple, non-drug treatments-aromatherapy and intravenous administration of a simple sugar solution-may offer effective new approaches to relieving nausea and vomiting after surgery, report a pair of studies in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Aug 2013

Fathers' extremely long working hours can be detrimental to their sons´ wellbeing

Fathers' extremely long working hours can be detrimental to their sons´ wellbeing. This is the key finding of a longitudinal study by Jianghong Li (senior researcher at the WZB Berlin Social Science Center) and four Australian co-authors, published in the Journal of Marriage and Family.

22 Aug 2013

Brain Study Suggests New Way To Treat Anxiety

...

22 Aug 2013

Appetite-Controlling Hormone Leaves Obese People Still Hungry

...

22 Aug 2013

Genenews Axes 60% Of Staff To Boost New JV

...

22 Aug 2013

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

...

22 Aug 2013

NIH Grants $5.2M To Vanderbilt Colon Cancer Investigator

...

22 Aug 2013

Novel Approach Developed On Antitumor Immunotherapy

...

22 Aug 2013

Aging Gene Tied To Myeloma

...

22 Aug 2013

PDI Expands Focus With Mdx Commercialization Deal

...

22 Aug 2013

Takeda Launches New Subsidiary In Peru

...

22 Aug 2013

Psychogenics Picks Up Alzheimer’s Animal Model From USF

PsychoGenics obtained an exclusive license from the University of South Florida to its APP/PS1 double transgenic mice, which co-express the M146L presenilin 1 (PS1) mutation and the double mutations at K670N/M671L (Swedish mutation) in the amyloid precursor protein (APP).

22 Aug 2013

International conference to focus on concepts of 'imperfection' in children

The word 'imperfection' is contentious, whether applied in a contemporary or historical sense and especially when used in the context of children; it assumes normative standards of behaviour, physical appearance, mental capacity or way of living, at the same time as it means very different things in particular ethnic, geographical or historical contexts.

22 Aug 2013

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.

22 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

First Edition: August 22, 2013

Today's headlines include news reports about how summer politics are shaking out around the health law's implementation.

22 Aug 2013

Finding a New Purpose for Old Drugs

An interview with Dr. Kate Hudson-Farmer about the methods used to discover new uses for old drugs.

From Clinigen Group 22 Aug 2013

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda Pharmaceutical Company Limited today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal antibody, for the treatment of adults with moderately to severely active ulcerative colitis and Crohn’s disease, were published in the August 22, 2013 issue of the New England Journal of Medicine.

22 Aug 2013